Join the club for FREE to access the whole archive and other member benefits.

In-silico drug modelling for treatment of stroke

10-Aug-2021

Key points from article :

Stroke and heart attack, occur when blockages cause blood flow to stop to certain tissues, resulting in lack of oxygen and cell death.

When this blood flow is restored, it leads to further damage, known as cerebral ischemia/reperfusion injury (CIRI).

A study conducted in the rats showed that autophagy prevented this and a rapalog named Eugenol enhanced this process.

Rapalogs are compounds that affect the mTOR pathways, named after the compound Rapamycin which is toxic when given in large quantities.

Computer modeling was used to screen for safer compounds that target the mTORC1 pathway by digitally recreating the binding site.

Libdock, a docking software was used to scan compounds that strongly bind to the binding site.

Another software called TOPKAT was used to scan these compounds for various toxicity parameters.

Two compounds that were found to be less mutagenic and less toxic were chosen for a follow-up study.

These compounds are yet to be tested in animal models.

Study by Jilin University, led by Di Ma, published in Aging.

Rapamycin analogs may help prevent cerebral ischemia/reperfusion injury (CIRI)

Mentioned in this article:

Click on resource name for more details.

Aging

Bio-medical journal covering research on all aspects of gerontology

Di Ma

Researcher in the Department of Neurology at the First Affiliated Hospital of Jilin University

Jilin University

University located in Changchun, the capital city of Jilin Province in Northeast China